Play all audios:
ABSTRACT THE treatment of collagen with hydroxylamine, which splits ester-like bonds, produces subunits carrying newly formed aspartic acid hydroxamates1,2. Their alcohol counterparts are
not yet fully identified. A series of investigations on the immunogenicity and specificity of collagen3,4 showed that collagen treated with hydroxylamine (HC) is an antigen which induces the
formation of two types of immune sera: type 1 containing only antibodies against the area of hydroxylamine treatment (HC-antibodies); type 2 containing additionally antibodies against the
general collagen structure. HC therefore acts when used for immunization like a conjugated protein. Investigation of haemagglutination inhibition showed that early sera were predominantly of
type 2. Hyperimmune sera, however, were mostly of type 1. Inhibition experiments proved that sera with only HC-antibodies (type 1 immune sera) can be inhibited by HC, but are not inhibited
by collagen preparations such as parent gelatine. Antisera which possess both antibodies (type 2 immune sera) are inhibited extensively by HC and to a lesser degree by parent gelatine.
Additionally, inhibition experiments were carried out with peptides obtained from HC, acid-soluble collagen and insoluble collagen by treatment with trypsin or colla-genase5. Only peptides
obtained from HC inhibited HC-antibodies and these peptides when used in sufficient amounts caused a complete inhibition of potent antisera. Access through your institution Buy or subscribe
This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 51 print issues and online access
$199.00 per year only $3.90 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are
calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS A
FRUCTOSYLATED PEPTIDE DERIVED FROM A COLLAGEN II T CELL EPITOPE FOR LONG-TERM TREATMENT OF ARTHRITIS (FIA-CIA) IN MICE Article Open access 30 August 2021 SERUM COMPONENTS INFLUENCE ANTIBODY
REACTIVITY TO GLYCAN AND DNA ANTIGENS Article Open access 22 August 2023 REGULATORY PROPERTIES OF VITRONECTIN AND ITS GLYCOSYLATION IN COLLAGEN FIBRIL FORMATION AND COLLAGEN-DEGRADING ENZYME
CATHEPSIN K ACTIVITY Article Open access 08 June 2021 REFERENCES * Gallop, P. M., Seifter, S., and Meilman, E., _Nature_, 183, 1659 (1959). Article ADS CAS Google Scholar * Blumenfeld,
O. O., and Gallop, P. M., _Biochemistry_, 1, 947 (1962). Article CAS Google Scholar * Steffen, C., Timpl, R., and Wolff, I., _Z. Immunitätsforsch._, 124, 476 (1962). Google Scholar *
Steffen, C., Timpl, R., and Wolff, I., _J. Immunol._, 93, 656 (1964). CAS PubMed Google Scholar * Steffen, C., and Timpl, R., _Z. Immunitätsforsch._, 130, 3 (1966). CAS Google Scholar *
Springer, G. F., and Williamson, P., _Biochem. J._, 85, 282 (1962). Article CAS Google Scholar * Hörmann, H., _Leder_, 11, 173 (1960). Google Scholar * Porter, R. R., and Press, E. M.,
_Ann. Rev. Biochem._, 31, 625 (1962). Article CAS Google Scholar Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Klinisches Laboratorium, Hanuschkrankenhaus, Vienna,
Austria C. STEFFEN, R. TIMPL & I. WOLFF Authors * C. STEFFEN View author publications You can also search for this author inPubMed Google Scholar * R. TIMPL View author publications You
can also search for this author inPubMed Google Scholar * I. WOLFF View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and
permissions ABOUT THIS ARTICLE CITE THIS ARTICLE STEFFEN, C., TIMPL, R. & WOLFF, I. Identification of an Antigenic Determinant of Collagen treated with Hydroxylamine. _Nature_ 213,
497–498 (1967). https://doi.org/10.1038/213497a0 Download citation * Issue Date: 04 February 1967 * DOI: https://doi.org/10.1038/213497a0 SHARE THIS ARTICLE Anyone you share the following
link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature
SharedIt content-sharing initiative